Skip to main content
Log in

An Integrated Pharmacodynamic Analysis of Erythropoietin, Reticulocyte, and Hemoglobin Responses in Acute Anemia

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. To determine by pharmacodynamic (PD) analysis physiologically relevant parameters of the cellular kinetics of erythropoiesis in acute anemia.

Methods. The PD relationships among erythropoietin (EPO), reticulocyte, and RBC (Hb) responses were investigated in young adult sheep in acute anemia induced twice by two controlled phlebotomies separated by a 4-week recovery period.

Results. The phlebotomies resulted in rapid increases in plasma EPO, with maximal levels occurring at 3 to 8 days, followed by a reticulocyte response with a delay of 0.5 to 1.5 days. The Hb returned to prephlebotomy base line at the end of the 4-week recovery period. The EPO, reticulocyte count, and Hb responses were well described by a PK/PD model (r = 0.975) with the following cellular kinetics parameters: the lag time between EPO activation of erythroid progenitor cells and reticulocyte formation; the reticulocyte-to-RBC maturation time; the reticulocyte and Hb formation efficacy coefficients, quantifying EPO's efficacy in stimulating the formation of reticulocytes and Hb, respectively; the C50 PK/PD transduction parameter defined as the EPO level resulting in half the maximum rate of erythropoiesis.

Conclusion. Physiologically relevant cellular kinetics parameters can be obtained by an endogenous PK/PD analysis of phlebotomy data and are useful for elucidating the pathophysiologic etiology of various anemias.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. S. H. Chapel, P. Veng-Pedersen, R. L. Schmidt, and J. A. Widness. A pharmacodynamic analysis of erythropoietin-stimulated reticulocyte response in phlebotomized sheep. J.Pharmacol.Exp.Ther. 295:346-351 (2000).

    PubMed  Google Scholar 

  2. J. A. Widness, R. L. Schmidt, P. Veng-Pedersen, N. Modi, and S. T. Sawyer. A sensitive and specific erythropoietin immunoprecipitation assay: Application to pharmacokinetic studies. J.Lab.Clin.Med. 119:285-294 (1992).

    PubMed  Google Scholar 

  3. C. Peters, M. K. Georgieff, P. A. de Alarcon, R. T. Cook, L. F. Burmeister, L. S. Lowe, and J. A. Widness. Effect of chronic erythropoietin administration on plasma iron in newborn lambs. Biol.Neonate 70:218-228 (1996).

    PubMed  Google Scholar 

  4. M. K. Georgieff, R. L. Schmidt, M. M. Mills, W. J. Radmer, and J. A. Widness. Fetal iron and cytochrome c status after intrauterine hypoxemia and erythropoietin administration. Am.J.Physiol. 262:R485-R491 (1992).

    PubMed  Google Scholar 

  5. J. W. Adamson, B. Torok-Storb, and N. Lin. Analysis of erythropoiesis by erythroid colony formation in culture. Blood Cells 4:89-103 (1978).

    PubMed  Google Scholar 

  6. M. C. Mackey and P. Dormer. Continuous maturation of proliferating erythroid precursors. Cell Tissue Kinet. 15:381-392 (1982).

    PubMed  Google Scholar 

  7. P. Veng-Pedersen. Curve fitting and modelling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFIT. J.Pharmacokinet.Biopharm. 5:513-531 (1977).

    PubMed  Google Scholar 

  8. M. F. Hutchinson and F. R. deHoog. Smoothing noise data with spline functions. Numer.Math. 47:99-106 (1985).

    Google Scholar 

  9. D. M. Mock, G. L. Lankford, J. A. Widness, L. F. Burmeister, D. Kahn, and R. G. Strauss. Measurement of red cell survival using biotin-labeled red cells: validation against 51Cr-labeled red cells. Transfusion 39:156-162 (1999).

    PubMed  Google Scholar 

  10. J. S. Kaufman, D. J. Reda, C. L. Fye, D. S. Goldfarb, W. G. Henderson, J. G. Kleinman, and C. A. Vaamonde. Subcutaneous compared with intravenous Epoetin in patients receiving hemodialysis. Department of Veterans Affairs Cooperative Study Group on Erythropoietin in Hemodialysis Patients. N.Engl.J.Med. 339:578-583 (1998).

    PubMed  Google Scholar 

  11. I. C. Macdougall, D. E. Roberts, G. A. Coles, and J. D. Williams. Clinical pharmacokinetics of Epoetin (recombinant human erythropoietin). Clin.Pharmacokinet. 20:99-113 (1991).

    PubMed  Google Scholar 

  12. S. F. Lui, W. W. Chung, C. B. Leung, K. Chan, and K. N. Lai. Pharmacokinetics and pharmacodynamics of subcutaneous and intraperitoneal administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis. Clin.Nephrol. 33:47-51 (1990).

    PubMed  Google Scholar 

  13. T. Salmonson, B. G. Danielson, and B. Wikstrom. Pharmacokinetics of recombinant human erythropoietin after intravenous and subcutaneous administration to healthy subjects. Br.J.Clin.Pharmacol. 29:709-713 (1990).

    PubMed  Google Scholar 

  14. W. H. Yoon, S. J. Park, I. C. Kim, and M. G. Lee. Pharmacokinetics of recombinant human erythropoietin in rabbits and 3/4 nephrectomized rats. Res.Commun.Mol.Pathol.Pharmacol. 96:227-240 (1997).

    PubMed  Google Scholar 

  15. A. Markham and H. M. Bryson. Epoetin alfa. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in nonrenal applications. Drugs 49:232-254 (1995).

    PubMed  Google Scholar 

  16. G. L. Wang and G. L. Semenza. General involvement of hypoxia-induced factor 1 in transcriptional response to hypoxia. Proc.Natl.Acad.Sci.USA 90:4304-4308 (1998).

    Google Scholar 

  17. K. Guillemin and M. A. Krasnow. The hypoxic response. Huffing and HITing. Cell 89:9-12 (1997).

    PubMed  Google Scholar 

  18. C. A. Finch, L. A. Harker, and J. D. Cook. Kinetics of the formed elements of human blood. Blood 50:699-707 (1977).

    PubMed  Google Scholar 

  19. E. Beutler, M. A. Lichtman, B. S. Coller, and T. J. Kipps. Williams Hematology, 5th ed. McGraw-Hill, New York (1995).

    Google Scholar 

  20. W. Krzyzanski, R. Ramakrishnan, and J. Jusko. Basic pharmaco-dynamic models for agents that alter production of natural cells. J.Pharmacokinet.Biopharm. 27:467-489 (2000).

    Google Scholar 

  21. H. Akaike. Automatic control: A new look at the statistical model identification. IEEE Trans.Control Theory 19:716-723 (1974).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. Veng-Pederson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Veng-Pederson, P., Chapel, S., Schmidt, P.R.L. et al. An Integrated Pharmacodynamic Analysis of Erythropoietin, Reticulocyte, and Hemoglobin Responses in Acute Anemia. Pharm Res 19, 1630–1635 (2002). https://doi.org/10.1023/A:1020797110836

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1020797110836

Navigation